TeaRx™ Multi-Parameter Diagnostic Assays to be Used in Dry Eye Syndrome Drug Trial

BioLight announced today that, DiagnosTear Ltd., one of BioLight’s subsidiaries, has signed a services agreement with a pharmaceuticals company, pursuant to which DiagnosTear will provide analysis services through its TeaRx™ multi-parameter diagnostic assays for use in an clinical trial for dry eye syndrome.

Link to complete article

Link to Newsroom

Comments are closed.